|
|
Volumn 21, Issue 7, 2010, Pages 843-854
|
|
Addition of a single E2 binding site to the human papillomavirus (HPV) type 16 long control region enhances killing of HPV positive cells via HPV E2 protein-regulated herpes simplex virus type 1 thymidine kinase-mediated suicide gene therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA BINDING PROTEIN;
E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16;
ONCOPROTEIN;
THYMIDINE KINASE;
ARTICLE;
BINDING SITE;
CELL LINE;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETICS;
HERPES SIMPLEX VIRUS 1;
HUMAN;
METABOLISM;
METHODOLOGY;
MOLECULAR GENETICS;
NUCLEOTIDE SEQUENCE;
PLASMID;
PROMOTER REGION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TUMOR CELL LINE;
UPREGULATION;
WESTERN BLOTTING;
BASE SEQUENCE;
BINDING SITES;
BLOTTING, WESTERN;
CELL LINE;
CELL LINE, TUMOR;
DNA-BINDING PROTEINS;
GENE EXPRESSION REGULATION;
GENE THERAPY;
HERPESVIRUS 1, HUMAN;
HUMANS;
MOLECULAR SEQUENCE DATA;
ONCOGENE PROTEINS, VIRAL;
PLASMIDS;
PROMOTER REGIONS, GENETIC;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
THYMIDINE KINASE;
UP-REGULATION;
|
|
EID: 77957958961
PISSN: None
EISSN: 15577422
Source Type: Journal
DOI: 10.1089/hum.2009.115 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
